(Q60707321)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Dopaminergic resistance in a case of invasive macroprolactinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

Assumpta Caixàs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

D Schwarzstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

A García-Patterson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

G Giménez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J Calaf

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

X Matías-Guiu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S M Webb

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 June 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

443-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03348879

25 October 2019

exact match

0 references

cites work

CV205-502, a new non-ergot dopamine agonist, reduces prolactinoma size in man.

1 reference

12 December 2020

Treatment of macroprolactinomas with a new non-ergot, long-acting dopaminergic drug, CV 205-502

1 reference

12 December 2020

Long term treatment with CV 205-502 in patients with prolactin-secreting pituitary macroadenomas

1 reference

12 December 2020

Malignant prolactinomas

1 reference

12 December 2020

The Efficacy and Tolerability of CV 205–502 (a Nonergot Dopaminergic Drug) in Macroprolactinoma Patients and in Prolactinoma Patients Intolerant to Bromocriptine

1 reference

12 December 2020

Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases

1 reference

12 December 2020

CV 205-502 treatment of hyperprolactinemia

1 reference

12 December 2020

Cerebellar metastasis from a prolactinoma during treatment with bromocriptine

1 reference

12 December 2020

CV 205-502: a new long-acting drug for inhibition of prolactin hypersecretion

1 reference

12 December 2020

Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*

1 reference

12 December 2020

Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride

1 reference

12 December 2020

Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride

1 reference

12 December 2020

Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR)

1 reference

12 December 2020

Multiple intracranial metastases from a prolactin secreting pituitary tumour.

1 reference

12 December 2020

Primary treatment of macroprolactinomas with Parlodel LAR®

1 reference

12 December 2020

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

1 reference

12 December 2020

Combined nonmetastasizing fibrosarcoma and chromophobe tumor of the pituitary.

1 reference

12 December 2020

Resistance to bromocriptine in prolactinomas

1 reference

12 December 2020

Diagnosis and management of hormone-secreting pituitary adenomas

1 reference

12 December 2020

Management of prolactinomas

1 reference

12 December 2020

An intracranial metastasis from a PRL secreting pituitary tumour

1 reference

12 December 2020

Malignant prolactinoma with multiple intracranial metastases studied with positron emission tomography

1 reference

12 December 2020

Bromocriptine in management of large pituitary tumours

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03348879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8103781%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference